BIO-RAD LABORATORIES, INC. (BIO-B) › Shareholders' EquityBIO-RAD LABORATORIES, INC. (BIO-B) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $1.26B2010: $1.54B2011: $1.74B2012: $2.02B2013: $2.19B2014: $2.18B2015: $2.49B2016: $2.58B2017: $2.93B2018: $4.02B2019: $5.76B2020: $9.89B2021: $13.69B2022: $9.62B2023: $8.74B2024: $6.57B2025: $7.45B$7.45B2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$7.45B+13.5%2024$6.57B-24.8%2023$8.74B-9.1%2022$9.62B-29.7%2021$13.69B+38.4%2020$9.89B+71.8%2019$5.76B+43.2%2018$4.02B+37.2%2017$2.93B+13.6%2016$2.58B+3.8%2015$2.49B+13.8%2014$2.18B-0.1%2013$2.19B+8.5%2012$2.02B+15.5%2011$1.74B+13.5%2010$1.54B+22.0%2009$1.26B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share